Investor Perspective: The Strategic Venturing Spectrum
10 November 2022 | Leiden (NL) & Virtual
Large corporations can use Corporate Venture Capital (CVC) as a vehicle to get early access to new innovations. They strategically look for companies developing assets and technologies that might complement their pipeline in the future. So how do CVCs maximize the value for their company with a balance between capital and strategic objectives?
Join this Johnson & Johnson Innovation hybrid event as investors from Pfizer Ventures, Leaps by Bayer, M Ventures and Johnson & Johnson Innovation – JJDC share their insights.